Elis S.A.
Elis SA engages in the provision of flat linen, workwear, and hygiene and well-being solutions in France, Central Europe, Scandinavia, Eastern Europe, the United Kingdom, Ireland, Latin America, Southern Europe, and internationally. The company offers table, bed, kitchen, patient, and bath linens; workwear and personal protective equipment; beverage solutions, such as water coolers and accessorie… Read more
Elis S.A. (0RA8) - Net Assets
Latest net assets as of June 2021: €2.92 Billion EUR
Based on the latest financial reports, Elis S.A. (0RA8) has net assets worth €2.92 Billion EUR as of June 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€7.95 Billion) and total liabilities (€5.03 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €2.92 Billion |
| % of Total Assets | 36.71% |
| Annual Growth Rate | 25.08% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 67.61 |
Elis S.A. - Net Assets Trend (2016–2020)
This chart illustrates how Elis S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Elis S.A. (2016–2020)
The table below shows the annual net assets of Elis S.A. from 2016 to 2020.
| Year | Net Assets | Change |
|---|---|---|
| 2020-12-31 | €2.81 Billion | -5.06% |
| 2019-12-31 | €2.96 Billion | +3.10% |
| 2018-12-31 | €2.87 Billion | -1.83% |
| 2017-12-31 | €2.92 Billion | +154.74% |
| 2016-12-31 | €1.15 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Elis S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 66860000000.0% over the analyzed period, indicating profitable operations and earnings retention.
- The company has 0.4% of equity in treasury stock, representing shares repurchased from the open market.
Current Equity Component Breakdown (December 2020)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €394.50 Million | 14.06% |
| Common Stock | €221.80 Million | 7.90% |
| Treasury Stock | €11.20 Million | 0.40% |
| Other Components | €2.20 Billion | 78.44% |
| Total Equity | €2.81 Billion | 100.00% |
Elis S.A. Competitors by Market Cap
The table below lists competitors of Elis S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Americold Realty Trust
NYSE:COLD
|
$3.22 Billion |
|
Loongson Technology Corp. Ltd. A
SHG:688047
|
$3.23 Billion |
|
Taiwan Business Bank
TW:2834
|
$3.23 Billion |
|
Arkema SA
PA:AKE
|
$3.23 Billion |
|
CNPC Capital Co Ltd
SHE:000617
|
$3.22 Billion |
|
Caitong Securities Co Ltd
SHG:601108
|
$3.22 Billion |
|
Axfood AB
ST:AXFO
|
$3.22 Billion |
|
Fuchs Petrolub AG Pfd. NV
LSE:0LCR
|
$3.22 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Elis S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2019 to 2020, total equity changed from 2,955,800,000 to 2,806,200,000, a change of -149,600,000 (-5.1%).
- Net income of 3,800,000 contributed positively to equity growth.
- Dividend payments of 33,200,000 reduced retained earnings.
- Share repurchases of 1,300,000 reduced equity.
- Other factors decreased equity by 118,900,000.
Equity Change Factors (2019 to 2020)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €3.80 Million | +0.14% |
| Dividends Paid | €33.20 Million | -1.18% |
| Share Repurchases | €1.30 Million | -0.05% |
| Other Changes | €-118.90 Million | -4.24% |
| Total Change | €- | -5.06% |
Book Value vs Market Value Analysis
This analysis compares Elis S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Elis S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.14%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.14%
- • Asset Turnover: 0.36x
- • Equity Multiplier: 2.80x
- Recent ROE (0.14%) is below the historical average (3.47%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 8.10% | 6.14% | 0.41x | 3.23x | €-21.73 Million |
| 2017 | 1.42% | 1.89% | 0.28x | 2.73x | €-250.51 Million |
| 2018 | 2.87% | 2.62% | 0.40x | 2.72x | €-204.48 Million |
| 2019 | 4.80% | 4.33% | 0.40x | 2.77x | €-153.58 Million |
| 2020 | 0.14% | 0.14% | 0.36x | 2.80x | €-276.82 Million |
Industry Comparison
This section compares Elis S.A.'s net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Elis S.A. (0RA8) | €2.92 Billion | 8.10% | 1.72x | $3.22 Billion |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |